Revolutionising Drug Delivery with Microalgae Extracellular Vesicles (MEVs).

We’re thrilled to share an exclusive interview with Manuel Vega, CEO and co-founder of AGS Therapeutics, in which he discusses the groundbreaking potential of MEVs as a universal delivery system for biologics, vaccines, and gene therapies.

In this compelling conversation, Manuel highlights:

✅ How MEVs overcome biological barriers to deliver payloads with unmatched precision.

✅ Innovations addressing unmet needs in ophthalmology, bowel diseases, CNS disorders, and more.

✅ The eco-friendly, scalable manufacturing process that makes MEVs accessible and sustainable.

‍

“We aim to foster a paradigm shift in drug delivery, unlocking the full medical potential of MEVs to benefit a wide spectrum of diseases.” Don’t miss this deep dive into the future of biomedicine.

‍